View allAll Photos Tagged brainstorming

035

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

1:00 PM

CONCURRENT LUNCH SOLUTION SESSIONS

PATIENT TRIALS WE CAN ACTUALLY LEARN FROM

Hosted by City of Hope

The cost to develop and gain FDA approval for a new drug today is more than $2.5 billion, according to the Tufts Center for the Study of Drug Development. Driving much of that cost are human clinical trials—a process that has long been the intellectual and regulatory scaffold supporting the drug development enterprise, and one that has barely changed over the past seven decades. Despite all that expenditure—which ultimately helps push up the price of medicines—we still often know little about whether even approved drugs will work in any one individual and why. Luckily, there are a number of innovative ideas for evaluating the safety and efficacy of new medicines that may give us more information, more quickly—and maybe even more cheaply too. A no-holds-barred roundtable.

Dr. Amy Abernethy, Chief Medical Officer, Chief Scientific Officer, and Senior Vice President, Oncology, Flatiron Health

 

Matt de Silva, Co-Founder, CEO and Director, Notable Labs

Kathy Giusti, Founder, Multiple Myeloma Research Foundation; Co-Chair, HBS Kraft Precision Medicine Accelerator

Dr. Linda Malkas, Professor and Associate Chair, Department of Molecular and Cellular Biology, City of Hope

Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation

Moderator: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

Brainstorming with an IT team at UVa on how their current process works.

Brainstorm @ Metalcamp 2008

002

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:05 PM

SETTING THE AGENDA: A BRAINSTORM HEALTH 3.0 REBOOT

The health ecosystem is evolving faster than ever before, as everything—from machine learning to biotracking to gene editing—advances with breakneck speed. But whether these innovations will transform global health for the better depends on something else: leadership. Today, those who run and shape every enterprise need to be health care leaders too. So we’ve framed our third annual gathering not just as an incubator of ideas, but also as a leadership summit. Our goals? To help you harness the power of innovation for your company and community—and to share smart solutions that can make all of us thrive a little bit more.

 

The Fortune Brainstorm Health Co-Chairs:

Dr. David B. Agus, Professor of Medicine and Engineering; Founding Director and CEO, Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California; Co-chair, Fortune Brainstorm Health

Arianna Huffington, Founder and CEO, Thrive Global; Co-chair, Fortune Brainstorm Health

Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

Fortune Brainstorm HEALTH 2018

March 19-20, 2018

Laguna Niguel, CA

 

The third Fortune Brainstorm HEALTH conference will be held March 19-20, 2018 in Laguna Niguel. We will again convene a powerful new community of leaders at the forefront of the revolution that is underway in 21st century healthcare.

 

2017 speakers included Joseph R. Biden, Jr., 47th Vice President, United States, CEOs Chip Bergh of Levi Strauss & Co. Mark Bertolini of Aetna, Tom Hayes of Tyson Foods, Arianna Huffington of Thrive Global, John Mackey of Whole Foods, Mike McNamara of Flex, Denise Morrison of Campbell Soup, and Timothy Wentworth of Express Scripts, as well as Duke University Surgical Oncologist (and Time 100 honoree) Dr. Shelley Hwang, Tempus Co-founder and Chair Eric Lefkofsky, Stanford University School of Medicine Dean Dr. Lloyd Minor, Venrock Partner Dr. Bryan Roberts, and Human Longevity Co-founder and Executive Chair Dr. J. Craig Venter. They were joined by our co-chairs—Fortune Editor-in-Chief Clifton Leaf, Time Executive Editor Siobhan O’Connor and Dr. David Agus, one of the world’s most influential physicians.

 

Fortune Brainstorm HEALTH, in association with IBM Watson Health, gathers not only C-suite leaders of top companies, hospitals, insurers, and cutting-edge pharma and biotech companies, but also titans of venture capital, tech and telecom, and other industries, all of who are rapidly changing the face of health care. The forum covered four pillars—personal wellness, intervention, research, and the value chain. Our aim is not only to push some boundaries in each of these areas, but also to show how businesses, both established and new, can lead the way. And, yes, as with all of our Brainstorm events, Fortune will disseminate these ideas on our website, in the magazine, on social media, and beyond.

 

Photograph by Stuart Isett/Fortune

026

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

11:10 AM

A MOTHER FIGHTS BACK: USING BIG DATA AND GENOMICS TO SILENCE HER SON’S KILLER

Theresa Beech’s 13-year-old son Daniel died nearly two years ago from osteosarcoma. Daniel’s killer: a pediatric bone cancer whose treatment—and survival rates—haven’t changed in 30 years. But the time for change is now. Driven by the hope that she can spare other families this same pain and loss, Theresa — a space engineer by day — has collected the genetic codes from more than 100 young patients whose parents donated the data. What she has discovered offers hope for progress at last. The unbelievable story of one woman’s race to cure a terrible cancer.

 

Theresa Beech, President, Because of Daniel

 

Photograph by Stuart Isett/Fortune

012

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

5:35 PM

THE NEXT BIG THING

When it comes to improving our health care systems through technology, the good ideas seem to be never-ending. Digital invention is plentiful; funding is rich. But so far, we’ve yet to see anything that moves the needle more than a little bit. Which brings us to a tough question: Is there a next big thing in healthtech—something that’s going to change human health or care the minute it comes into existence? And if so, where will it come from? Our conversation with two visionaries in the field.

 

Dr. Jessica Mega, Chief Medical Officer, Verily

Dr. Bryan Roberts, Partner, Venrock

Moderator: Michal Lev-Ram, Senior Writer and Co-chair, Most Powerful Women Summit, MPW Next Gen, and Brainstorm TECH, Fortune

 

Photograph by Stuart Isett/Fortune

012

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

5:35 PM

THE NEXT BIG THING

When it comes to improving our health care systems through technology, the good ideas seem to be never-ending. Digital invention is plentiful; funding is rich. But so far, we’ve yet to see anything that moves the needle more than a little bit. Which brings us to a tough question: Is there a next big thing in healthtech—something that’s going to change human health or care the minute it comes into existence? And if so, where will it come from? Our conversation with two visionaries in the field.

 

Dr. Jessica Mega, Chief Medical Officer, Verily

Dr. Bryan Roberts, Partner, Venrock

Moderator: Michal Lev-Ram, Senior Writer and Co-chair, Most Powerful Women Summit, MPW Next Gen, and Brainstorm TECH, Fortune

 

Photograph by Stuart Isett/Fortune

020

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

9:05 AM

THE NEXT ENDANGERED SPECIES: THE DOCTOR

Lost in the conversation of the digital health revolution is the focus on humans that often drive transformation in healthcare and that’s the medical doctor. We’ve seen doctors increasingly demoralized, depressed, and under pressure to meet mounting administrative loads while maintaining impeccable, patient-rated “healthgrades” online. The epidemic of burnout now affects almost two-thirds of America’s physicians according to a recent Medscape study. They’re frustrated by the payment systems and being pushed out by large health systems that imagine others doing their work and stripping them of authority. They spend less and less time with patients, and there’s giddy talk about how soon robots—already active in surgery and radiology—will do it all. Do we really want to imagine a world without doctors?

 

Dr. Toby Cosgrove, Former President and CEO, Cleveland Clinic

Dr. Laurie Glimcher, President and CEO, Dana-Farber Cancer Institute

Moderator: Dr. David B. Agus, University of Southern California

 

Photograph by Stuart Isett/Fortune

001

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

  

11:30 AM–1:00 PM

OPENING LUNCH: THE MOMENT OF TRUTH FOR DRUG DEVELOPMENT

Hosted by PAREXEL

 

The rising cost of failure. Lack of productivity gains. Intense pressure on prices and escalating demands to demonstrate value. All these factors are threatening the sustainability of pharmaceutical development, at a time when advances in medical science should be translating into significant gains for the industry and society. But a new class of technologies and patient-centric approaches may soon alter the playing field in a big way, allowing drug developers to leverage everything from real world data, to the use of precision medicine and cross-silo collaboration—driving up success rates and the value proposition for new medicines. We dig into the latest marvels in pharmaceutical development, discuss new research findings and probe how the transformative role of data might prove decisive for the future of the industry.

 

Dr. Udit Batra, CEO, MilliporeSigma

David Humphreys, Head of Healthcare U.S., Economist Intelligence Unit

Bernard Munos, Senior Fellow, FasterCures, a center of the Milken Institute

Paul Rejto, Executive Director and Head of Oncology Translational Research, Pfizer

Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation

Moderator: Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm Health

Introduction by: Dr. Alberto Grignolo, Corporate Vice President, Global Strategy, PAREXEL Consulting

  

Photograph by Stuart Isett/Fortune

001

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

  

11:30 AM–1:00 PM

OPENING LUNCH: THE MOMENT OF TRUTH FOR DRUG DEVELOPMENT

Hosted by PAREXEL

 

The rising cost of failure. Lack of productivity gains. Intense pressure on prices and escalating demands to demonstrate value. All these factors are threatening the sustainability of pharmaceutical development, at a time when advances in medical science should be translating into significant gains for the industry and society. But a new class of technologies and patient-centric approaches may soon alter the playing field in a big way, allowing drug developers to leverage everything from real world data, to the use of precision medicine and cross-silo collaboration—driving up success rates and the value proposition for new medicines. We dig into the latest marvels in pharmaceutical development, discuss new research findings and probe how the transformative role of data might prove decisive for the future of the industry.

 

Dr. Udit Batra, CEO, MilliporeSigma

David Humphreys, Head of Healthcare U.S., Economist Intelligence Unit

Bernard Munos, Senior Fellow, FasterCures, a center of the Milken Institute

Paul Rejto, Executive Director and Head of Oncology Translational Research, Pfizer

Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation

Moderator: Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm Health

Introduction by: Dr. Alberto Grignolo, Corporate Vice President, Global Strategy, PAREXEL Consulting

  

Photograph by Stuart Isett/Fortune

DECENTRALIZATION REVOLUTION

New technology makes it possible to move money and assets without banks or exchanges. Does this mean massive disruption for the financial services industry? Or will blockchain-based businesses play more supporting roles in the existing system, rather than replace it?

Jeremy Allaire, Chief Executive Officer, Circle

Amber Baldet, Chief Executive Officer, Clovyr

Barry Silbert, Chief Executive Officer, Digital Currency Group

Moderator: Jeff Roberts, FORTUNE

 

Photography by Rebecca Greenfield/Fortune

040

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

3:35 PM

WHY DON’T WE TALK ABOUT DEATH?

Consider this: 70 percent of Americans want to die at home. Only 30 percent do. And yet we spend an awful lot of money giving people an end of life they don’t want: Medicare, for instance, spends nearly 30 percent of its annual outlays on individuals in the last year of their lives. Meanwhile, caregivers shoulder an enormous burden as they help loved ones in their final months and years. How did we end up here? One reason: we don’t talk about it. Well, guess what: we’re about to start.

 

Alexandra Drane, Co-founder, ARCHANGELS; Co-founder, Eliza Corporation

Michael Hebb, Founder, Death over Dinner

Venerable Tenzin Priyadarshi, Director, Ethics Initiative, MIT Media Lab

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

030

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

12:10 PM

FROM CLOUD HOSPITALS TO HUMAN CELL PRINTING: HOW CHINA IS LEADING THE WAY

Chinese entrepreneurs and leaders are racing to develop health care solutions that can better serve the country’s 1.3 billion people—and much of the inspiration for these innovations is home-grown. As China takes leaps forward in digital connectivity, big data analytics, 3D printing, and artificial intelligence, other nations—including some industrial giants—are suddenly finding themselves in the slow lane, held back by budget cuts, red tape, and entrenched systems. Some insights from one health care pioneer on what it will take to stay competitive in the global race to innovate.

 

Dr. Jiren Liu, Chairman and CEO, Neusoft Corporation

Interviewer: Dr. David B. Agus, University of Southern California

 

Photograph by Stuart Isett/Fortune

014

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

7:00 PM–9:00 PM

DINNER AND FEATURED INTERVIEW

Hosted by IBM Watson Health

 

WELCOME

Deborah DiSanzo, General Manager, IBM Watson Health

 

THE SECRET TO TONY ROBBINS’ SUCCESS

He’s the go-to life and business strategist for high-octane CEOs, athletes, celebrities, and politicians. And, his empire of seminars, books, audio, video, and life training programs has empowered more than 50 million people from 100 countries who may not be lucky enough to have him on speed dial. Tony Robbins insists he can teach anyone to be confident, but where did the CEO Whisperer’s own strength come from? Fresh from another wildly popular “Unleash the Power Within” event, here’s Robbins as you’ve never seen him before. Joining us for an intimate interview in which he shares his own difficult personal upbringing, Robbins reveals how he went from homeless to household name—and how he can teach anyone else to believe in themselves.

 

Tony Robbins, Life and Business Strategist; Author, Unshakeable, Money: Master the Game

Interviewer: Dr. David B. Agus, University of Southern California

 

Photograph by Stuart Isett/Fortune

Brainstorm for "Candushima" poster.

036

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

1:00 PM

CONCURRENT LUNCH SOLUTION SESSIONS

MEDICAL INGENUITY — AT HALF THE PRICE

Hosted by Abbott

One thing we are very good at: creating medical marvels. Not so good at: making them affordable. So how do you squeeze more value out of innovation? One answer is to bring affordability into the ideation and design process from the very beginning. A conversation that probes the least explored part of ingenuity: patient value.

Jeffrey Brewer, Co-founder, President and CEO,, Bigfoot Biomedical

 

Dr. Toby Cosgrove, Former President and CEO, Cleveland Clinic

Dr. Jiren Liu, Founder, Chairman, and CEO, Neusoft Corp.

Jared Watkin, Senior Vice President, Diabetes Care, Abbott

Moderator: Michal Lev-Ram, Fortune

 

Photograph by Stuart Isett/Fortune

034

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

1:00 PM

CONCURRENT LUNCH SOLUTION SESSIONS

HEALTH CARE AND THE FOURTH INDUSTRIAL REVOLUTION

Hosted by Herman Miller

The industrial revolutions of yore heralded a transition from hand-powered production methods to machine-driven ones and the advent of mass production. The next industrial revolution is a decidedly digital one—and its implications for health care may be more significant than for any other industry. Far beyond telemedicine, the digital age isn’t just changing how we do medicine, but also how we define it. From the health gig economy to AI-run hospitals to on-demand diagnostics, technology is prompting a never-ending question: Where will this fourth revolution take us next?

 

Hema Budaraju, Product Lead, Health, Facebook

Sally Daub, CEO, Enlitic

Sajid Rahman, CEO, Telenor Health

Dr. Roy Schoenberg, President and CEO, American Well

Owen Tripp, Co-Founder and CEO, Grand Rounds

Moderator: Dr. David B. Agus, University of Southern California

Introduction: Mike O’Toole, Senior Vice President of Sales, Herman Miller

 

Photograph by Stuart Isett/Fortune

020

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

9:05 AM

THE NEXT ENDANGERED SPECIES: THE DOCTOR

Lost in the conversation of the digital health revolution is the focus on humans that often drive transformation in healthcare and that’s the medical doctor. We’ve seen doctors increasingly demoralized, depressed, and under pressure to meet mounting administrative loads while maintaining impeccable, patient-rated “healthgrades” online. The epidemic of burnout now affects almost two-thirds of America’s physicians according to a recent Medscape study. They’re frustrated by the payment systems and being pushed out by large health systems that imagine others doing their work and stripping them of authority. They spend less and less time with patients, and there’s giddy talk about how soon robots—already active in surgery and radiology—will do it all. Do we really want to imagine a world without doctors?

 

Dr. Toby Cosgrove, Former President and CEO, Cleveland Clinic

Dr. Laurie Glimcher, President and CEO, Dana-Farber Cancer Institute

Moderator: Dr. David B. Agus, University of Southern California

 

Photograph by Stuart Isett/Fortune

020

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

9:05 AM

THE NEXT ENDANGERED SPECIES: THE DOCTOR

Lost in the conversation of the digital health revolution is the focus on humans that often drive transformation in healthcare and that’s the medical doctor. We’ve seen doctors increasingly demoralized, depressed, and under pressure to meet mounting administrative loads while maintaining impeccable, patient-rated “healthgrades” online. The epidemic of burnout now affects almost two-thirds of America’s physicians according to a recent Medscape study. They’re frustrated by the payment systems and being pushed out by large health systems that imagine others doing their work and stripping them of authority. They spend less and less time with patients, and there’s giddy talk about how soon robots—already active in surgery and radiology—will do it all. Do we really want to imagine a world without doctors?

 

Dr. Toby Cosgrove, Former President and CEO, Cleveland Clinic

Dr. Laurie Glimcher, President and CEO, Dana-Farber Cancer Institute

Moderator: Dr. David B. Agus, University of Southern California

 

Photograph by Stuart Isett/Fortune

THE WORLD WIDE “WHEN?”

Emerging markets represent some of the world’s most important economic regions in the world. How soon will they ascend the global stage? Hear from the financiers and businesspeople greasing the gears of social mobility from Latin America to Southeast Asia.

Reuben Lai, Senior Managing Director, Grab Financial

Paulo Passoni, Managing Investment Partner, Innovation Fund, SoftBank

Shivani Siroya, Founder and CEO, Tala

Moderator: Alan Murray, Chief Executive Officer, FORTUNE

 

Photography by Rebecca Greenfield/Fortune

001

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

  

11:30 AM–1:00 PM

OPENING LUNCH: THE MOMENT OF TRUTH FOR DRUG DEVELOPMENT

Hosted by PAREXEL

 

The rising cost of failure. Lack of productivity gains. Intense pressure on prices and escalating demands to demonstrate value. All these factors are threatening the sustainability of pharmaceutical development, at a time when advances in medical science should be translating into significant gains for the industry and society. But a new class of technologies and patient-centric approaches may soon alter the playing field in a big way, allowing drug developers to leverage everything from real world data, to the use of precision medicine and cross-silo collaboration—driving up success rates and the value proposition for new medicines. We dig into the latest marvels in pharmaceutical development, discuss new research findings and probe how the transformative role of data might prove decisive for the future of the industry.

 

Dr. Udit Batra, CEO, MilliporeSigma

David Humphreys, Head of Healthcare U.S., Economist Intelligence Unit

Bernard Munos, Senior Fellow, FasterCures, a center of the Milken Institute

Paul Rejto, Executive Director and Head of Oncology Translational Research, Pfizer

Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation

Moderator: Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm Health

Introduction by: Dr. Alberto Grignolo, Corporate Vice President, Global Strategy, PAREXEL Consulting

  

Photograph by Stuart Isett/Fortune

Fortune Brainstorm HEALTH 2018

March 19-20, 2018

Laguna Niguel, CA

 

The third Fortune Brainstorm HEALTH conference will be held March 19-20, 2018 in Laguna Niguel. We will again convene a powerful new community of leaders at the forefront of the revolution that is underway in 21st century healthcare.

 

2017 speakers included Joseph R. Biden, Jr., 47th Vice President, United States, CEOs Chip Bergh of Levi Strauss & Co. Mark Bertolini of Aetna, Tom Hayes of Tyson Foods, Arianna Huffington of Thrive Global, John Mackey of Whole Foods, Mike McNamara of Flex, Denise Morrison of Campbell Soup, and Timothy Wentworth of Express Scripts, as well as Duke University Surgical Oncologist (and Time 100 honoree) Dr. Shelley Hwang, Tempus Co-founder and Chair Eric Lefkofsky, Stanford University School of Medicine Dean Dr. Lloyd Minor, Venrock Partner Dr. Bryan Roberts, and Human Longevity Co-founder and Executive Chair Dr. J. Craig Venter. They were joined by our co-chairs—Fortune Editor-in-Chief Clifton Leaf, Time Executive Editor Siobhan O’Connor and Dr. David Agus, one of the world’s most influential physicians.

 

Fortune Brainstorm HEALTH, in association with IBM Watson Health, gathers not only C-suite leaders of top companies, hospitals, insurers, and cutting-edge pharma and biotech companies, but also titans of venture capital, tech and telecom, and other industries, all of who are rapidly changing the face of health care. The forum covered four pillars—personal wellness, intervention, research, and the value chain. Our aim is not only to push some boundaries in each of these areas, but also to show how businesses, both established and new, can lead the way. And, yes, as with all of our Brainstorm events, Fortune will disseminate these ideas on our website, in the magazine, on social media, and beyond.

 

Photograph by Stuart Isett/Fortune

A view of the Brainstorming session on “Cyber Crime – Way to Arrest the Problem” held on 25th June, 2019, in Guwahati.

011

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

5:10 PM

PRECISION MEDICINE: WHERE IT’S WORKING AND WHY

The tools of molecular medicine, today, are homing in on human disease with a precision that could only be imagined a decade ago. New advances in big data, genomic medicine, and supercomputing are paving the way for targeted, personalized treatment. What has been the clinical impact so far—and what can we really expect in the five years to come? A deep dive with three individuals who are putting these tools into practice.

 

Kathy Giusti, Founder, Multiple Myeloma Research Foundation (MMRF); Faculty Co-chair, Kraft Precision Medicine Accelerator, Harvard Business School

Othman Laraki, Co-Founder and CEO, Color

Dr. Vijay Pande, General Partner, Andreessen Horowitz

Moderator: Dr. David B. Agus, University of Southern California

 

Photograph by Stuart Isett/Fortune

004

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:45 PM

MENTAL HEALTH: THE MISSING LINK ON THE HEALTH CARE CONTINUUM

Mental health disorders are the leading cause of disability worldwide, and yet too often, we treat them as a separate domain from human health: We cut off the head from the body, as Kaiser Permanente CEO Bernard J. Tyson puts it. This separation isn’t just wrongheaded, say public health experts, it’s dangerous. An extraordinary conversation about changing that paradigm—from clinic to culture. How insights into depression, anxiety, and addiction can offer surprising clues to where the body breaks down, how to fix it….and, yes, how to talk about it.

 

Deborah DiSanzo, General Manager, IBM Watson Health

Amy Powell, President, Paramount Television and Digital Entertainment

Bernard J. Tyson, Chairman and CEO, Kaiser Permanente

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

003

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:20 PM

U.S. HEALTH CARE: AT THE CROSSROADS

A whole lot has changed since Mark Bertolini, back in 2010, took the helm at Aetna, the (now) $63 billion health insurer: The Affordable Care Act, barely then a law, has launched and (kind of) death spiraled. Opioids have become an acknowledged public health enemy. Wellness has become a corporate mantra. Big data, AI, and blockchain, once mere Silicon Valley buzzwords, have become ways of business that health care companies cannot ignore. The whole system has consolidated, while a formidable crew of outsiders—Google, Apple, Amazon—appear poised to disrupt everything. Bertolini has been at the center of it all—in an intimate and candid conversation with Fortune Editor-in-Chief Clifton Leaf, he’ll talk about navigating one of the nation’s largest health insurers (and the 43rd-largest public company in America) through these waters, and about his final act—Aetna’s transformational deal with CVS—and what it means about the future of health care in America.

 

Mark Bertolini, Chairman and CEO, Aetna Inc.

Interviewer: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

017

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

7:45 AM

CONCURRENT BREAKFAST SOLUTION SESSIONS

THE END OF HEALTH CARE PRIVACY… AND IS IT A GOOD THING?

Someone forgot to tell consumers to be careful. Over the past several years, people everywhere have zealously shared their intimate health data with products and services like 23AndMe, FitBit, and the Apple Watch—eager to be guinea pigs in the grand Big Data Experiment of Human Health. But when it comes to the broader medical universe, a matrix of rules and proprietary interests have made discovery from this deep data reservoir restrictive and challenging. Some, likewise, blame the frustrating lack of interoperability in health systems on a misreading of privacy protections—as well as on the unwillingness of private companies to play in the same data sandbox. How do we harness our limitless health-related data while still protecting individual privacy? And here’s a provocative question to start us off: Is privacy all it’s cracked up to be?

 

Anu Acharya, CEO, Mapmygenome

Dr. Kevin Ban, Chief Medical Officer, athenahealth

Colin Hill, Co-Founder, Chairman and CEO, GNS Healthcare

Chrissa McFarlane, Chief Executive Officer, Patientory

Dr. Eric Topol, Founder and Director, Scripps Translational Science Institute; Executive VP and Professor, Molecular Medicine, The Scripps Research Institute

Hal Wolf, President and CEO, Healthcare Information and Management Systems Society

Moderator: Dr. David B. Agus, University of Southern California

 

Photograph by Stuart Isett/Fortune

039

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

3:05 PM

SEEING AROUND THE CORNER: THE SEARCH FOR A UNIVERSAL FLU VACCINE

This year marks not only a particularly brutal flu season in the U.S., but also the 100th anniversary of the 1918 Spanish Flu. That historic pandemic infected 500 million people, killing 50 million — or five percent of the world’s population. With hundreds of thousands of people still dying annually from the seasonal flu, how long before a universal flu vaccine is a reality? We’ll hear from one leader working feverishly to make sure we’re protected next time a killer bug hits home.

 

Dr. Bruce Gellin, President, Global Immunization, Sabin Vaccine Institute

 

Photograph by Stuart Isett/Fortune

005

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

3:10 PM

THE BORDERLESS WORLD

If we’ve learned anything over past decades as we shape health care policy, it’s that the lines on the global map are thin and permeable, when they exist at all. From the spread of disease and emerging pathogens to the logistics of drug development and medical manufacturing, borders are increasingly irrelevant. We press some globally minded thinkers on how enterprises can manage the challenges of an increasingly connected planet—and better yet, tap the power of a connected world.

 

Joe Almeida, Chairman, President and CEO, Baxter International

George Barrett, Executive Chairman, Cardinal Health

Michael Milken, Chairman, Milken Institute

Moderator: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

025

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

10:45 AM

CLIMBING OUT OF LAST PLACE: WEST VIRGINIA AND WELL-BEING

West Virginia consistently ranks last out of the 50 U.S. states when it comes to well-being—with the state levels of obesity, poverty, unemployment, and opioid abuse at or near the worst in the nation. But a surprising ray of hope is on the horizon—a new clinical program designed to help the Mountain State address these issues in a radical way. We offer an early look.

 

Dr. E. Gordon Gee, President, West Virginia University

Dr. Clay Marsh, Vice President and Executive Dean for Health Sciences, West Virginia University

Dr. Ali Rezai, Executive Chair, Vice President and Associate Dean, WVU Rockefeller Neuroscience Institute

 

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

011

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

5:10 PM

PRECISION MEDICINE: WHERE IT’S WORKING AND WHY

The tools of molecular medicine, today, are homing in on human disease with a precision that could only be imagined a decade ago. New advances in big data, genomic medicine, and supercomputing are paving the way for targeted, personalized treatment. What has been the clinical impact so far—and what can we really expect in the five years to come? A deep dive with three individuals who are putting these tools into practice.

 

Kathy Giusti, Founder, Multiple Myeloma Research Foundation (MMRF); Faculty Co-chair, Kraft Precision Medicine Accelerator, Harvard Business School

Othman Laraki, Co-Founder and CEO, Color

Dr. Vijay Pande, General Partner, Andreessen Horowitz

Moderator: Dr. David B. Agus, University of Southern California

 

Photograph by Stuart Isett/Fortune

A larger crowd, now brainstorming

021

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

9:30 AM

THE POWER OF BEDSIDE DATA

A technology that monitors a person’s respiratory rate, heart rate and movement may not seem, at first, like much of an innovation—but consider that EarlySense does this by way of a sensor slipped under your mattress. That allows staff at anywhere from hospitals to nursing homes keep an electronic eye on non-critical patients’ vital signs—in a way that doesn’t have to be invasive. Princess and the Pea: Meet the digital age.

 

Dr. Karissa Price-Rico, COO, EarlySense Ltd.

  

Photograph by Stuart Isett/Fortune

001A

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

  

1:00-1:45 PM

SPEAKER RECEPTION

 

Photograph by Stuart Isett/Fortune

022

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

9:35 AM

CAN A MACHINE STAFF YOUR HOSPITAL?

It has been called the great mismatch: legions of applicants for today’s 21st-century jobs aren’t prepared for the many positions available; meanwhile tens of thousands of talented people aren’t getting to put their skills to use—and the challenge is particularly acute in the health care economy. Meet the founder of one startup who believes she has the solution: using machine learning to find people with the traits most likely to make them great performers.

 

Kristen Hamilton, CEO and Co-founder, Koru

 

Photograph by Stuart Isett/Fortune

039

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

3:05 PM

SEEING AROUND THE CORNER: THE SEARCH FOR A UNIVERSAL FLU VACCINE

This year marks not only a particularly brutal flu season in the U.S., but also the 100th anniversary of the 1918 Spanish Flu. That historic pandemic infected 500 million people, killing 50 million — or five percent of the world’s population. With hundreds of thousands of people still dying annually from the seasonal flu, how long before a universal flu vaccine is a reality? We’ll hear from one leader working feverishly to make sure we’re protected next time a killer bug hits home.

 

Dr. Bruce Gellin, President, Global Immunization, Sabin Vaccine Institute

 

Photograph by Stuart Isett/Fortune

Fortune Brainstorm HEALTH 2018

March 19-20, 2018

Laguna Niguel, CA

 

The third Fortune Brainstorm HEALTH conference will be held March 19-20, 2018 in Laguna Niguel. We will again convene a powerful new community of leaders at the forefront of the revolution that is underway in 21st century healthcare.

 

2017 speakers included Joseph R. Biden, Jr., 47th Vice President, United States, CEOs Chip Bergh of Levi Strauss & Co. Mark Bertolini of Aetna, Tom Hayes of Tyson Foods, Arianna Huffington of Thrive Global, John Mackey of Whole Foods, Mike McNamara of Flex, Denise Morrison of Campbell Soup, and Timothy Wentworth of Express Scripts, as well as Duke University Surgical Oncologist (and Time 100 honoree) Dr. Shelley Hwang, Tempus Co-founder and Chair Eric Lefkofsky, Stanford University School of Medicine Dean Dr. Lloyd Minor, Venrock Partner Dr. Bryan Roberts, and Human Longevity Co-founder and Executive Chair Dr. J. Craig Venter. They were joined by our co-chairs—Fortune Editor-in-Chief Clifton Leaf, Time Executive Editor Siobhan O’Connor and Dr. David Agus, one of the world’s most influential physicians.

 

Fortune Brainstorm HEALTH, in association with IBM Watson Health, gathers not only C-suite leaders of top companies, hospitals, insurers, and cutting-edge pharma and biotech companies, but also titans of venture capital, tech and telecom, and other industries, all of who are rapidly changing the face of health care. The forum covered four pillars—personal wellness, intervention, research, and the value chain. Our aim is not only to push some boundaries in each of these areas, but also to show how businesses, both established and new, can lead the way. And, yes, as with all of our Brainstorm events, Fortune will disseminate these ideas on our website, in the magazine, on social media, and beyond.

 

Photograph by Stuart Isett/Fortune

Brainstorming en groupe pour réaliser le BMC autour d'une idée.

Atelier animé Guillaume Chevallier, co-fondateur de Le Shift

le-shift.co/

022

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

9:35 AM

CAN A MACHINE STAFF YOUR HOSPITAL?

It has been called the great mismatch: legions of applicants for today’s 21st-century jobs aren’t prepared for the many positions available; meanwhile tens of thousands of talented people aren’t getting to put their skills to use—and the challenge is particularly acute in the health care economy. Meet the founder of one startup who believes she has the solution: using machine learning to find people with the traits most likely to make them great performers.

 

Kristen Hamilton, CEO and Co-founder, Koru

 

Photograph by Stuart Isett/Fortune

014

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

7:00 PM–9:00 PM

DINNER AND FEATURED INTERVIEW

Hosted by IBM Watson Health

 

WELCOME

Deborah DiSanzo, General Manager, IBM Watson Health

 

THE SECRET TO TONY ROBBINS’ SUCCESS

He’s the go-to life and business strategist for high-octane CEOs, athletes, celebrities, and politicians. And, his empire of seminars, books, audio, video, and life training programs has empowered more than 50 million people from 100 countries who may not be lucky enough to have him on speed dial. Tony Robbins insists he can teach anyone to be confident, but where did the CEO Whisperer’s own strength come from? Fresh from another wildly popular “Unleash the Power Within” event, here’s Robbins as you’ve never seen him before. Joining us for an intimate interview in which he shares his own difficult personal upbringing, Robbins reveals how he went from homeless to household name—and how he can teach anyone else to believe in themselves.

 

Tony Robbins, Life and Business Strategist; Author, Unshakeable, Money: Master the Game

Interviewer: Dr. David B. Agus, University of Southern California

 

Photograph by Stuart Isett/Fortune

006

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

3:35 PM

IN DEFENSE OF SCIENCE

We live in a time of mind-boggling change and technological advance. Cars drive themselves. Robots perform surgery. Phones can probe the connections of the universe. And humans edit the molecular instructions that shape their very humanity. Yet even as we hurtle through this futuristic present, swept up in discovery and innovation, a surprisingly powerful force is pushing back from the horizon: the fear of science. That force has rallied to challenge the foundation of science itself, undermining scientific research—and, yes, public health and safety. Now, more than ever, the field requires investment and talent, both of which are imperiled. How can we most effectively respond to this assault? What can be done to restore trust in science and fact? And how can we promote investment in science, and draw a new generation of enterprising thinkers to the field?

Dr. Susan Desmond-Hellmann, Chief Executive Officer, Bill & Melinda Gates Foundation

Dr. Margaret Hamburg, President, American Association for the Advancement of Science

Dr. Lloyd Minor, Carl and Elizabeth Naumann Dean, Stanford University School of Medicine

Moderator: Dr. David B. Agus, University of Southern California

 

Photograph by Stuart Isett/Fortune

002

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:05 PM

SETTING THE AGENDA: A BRAINSTORM HEALTH 3.0 REBOOT

The health ecosystem is evolving faster than ever before, as everything—from machine learning to biotracking to gene editing—advances with breakneck speed. But whether these innovations will transform global health for the better depends on something else: leadership. Today, those who run and shape every enterprise need to be health care leaders too. So we’ve framed our third annual gathering not just as an incubator of ideas, but also as a leadership summit. Our goals? To help you harness the power of innovation for your company and community—and to share smart solutions that can make all of us thrive a little bit more.

 

The Fortune Brainstorm Health Co-Chairs:

Dr. David B. Agus, Professor of Medicine and Engineering; Founding Director and CEO, Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California; Co-chair, Fortune Brainstorm Health

Arianna Huffington, Founder and CEO, Thrive Global; Co-chair, Fortune Brainstorm Health

Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

001

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

  

11:30 AM–1:00 PM

OPENING LUNCH: THE MOMENT OF TRUTH FOR DRUG DEVELOPMENT

Hosted by PAREXEL

 

The rising cost of failure. Lack of productivity gains. Intense pressure on prices and escalating demands to demonstrate value. All these factors are threatening the sustainability of pharmaceutical development, at a time when advances in medical science should be translating into significant gains for the industry and society. But a new class of technologies and patient-centric approaches may soon alter the playing field in a big way, allowing drug developers to leverage everything from real world data, to the use of precision medicine and cross-silo collaboration—driving up success rates and the value proposition for new medicines. We dig into the latest marvels in pharmaceutical development, discuss new research findings and probe how the transformative role of data might prove decisive for the future of the industry.

 

Dr. Udit Batra, CEO, MilliporeSigma

David Humphreys, Head of Healthcare U.S., Economist Intelligence Unit

Bernard Munos, Senior Fellow, FasterCures, a center of the Milken Institute

Paul Rejto, Executive Director and Head of Oncology Translational Research, Pfizer

Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation

Moderator: Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm Health

Introduction by: Dr. Alberto Grignolo, Corporate Vice President, Global Strategy, PAREXEL Consulting

  

Photograph by Stuart Isett/Fortune

1 2 ••• 74 75 76 77 78 80